Accueil   Diary - News   All news VEINSOUND



VEINSOUND : a disruptive technology


It is with the support of the famous LABTAU, a well-know laboratory of INSERM (medical research institute) that VEINSOUND project is born.


Our Target? -> To treat varicose veins with an extracorporeal method without surgery or injection of drugs.


Our Goal?  -> To bring the VEINSOUND varicose veins treatment to the phlebologist’s office and make the treatment as simple as an ultrasound scanner exam.


Our Market? -> When one come to know that 20 to 25% of the population of industrialized countries is affected by this pathology, one doesn’t need to be a genius to guess the need. And the actual techniques don’t bring an efficient answer.


Located in Lyon (France), our structure is entering in its development phase and after a promising proof of concept realized in collaboration with LABTAU, we enter in a pre-clinical trial leading to a clinical trial.


Our Team? -> A very complementary team cumulating more than 60 years of experience in medtech development and high technology in successful well-known start-ups of Auvergne Rhône-Alpes region.


In order to support this launching, we rely on private investors and on BPI (Banque Pulique d’Investissement) and FUS foundation (foundation for therapeutic ultrasounds) in order to sustain our development. Actually, we offer the opportunity to investor partners to participate to a very innovative project, with a disruptive technology and a high potential.


We would like to take the opportunity to thank Lyonbiopole and its team for its support and the quality of professional exchanges which represents a major asset in the development of VEINSOUND in Auvergne Rhône-Alpes.